Global Pulmonary Arterial Hypertension (PAH) Drugs Market Research Report 2017

August 2017 | 118 pages | ID: G324A2DD7D9EN
QYResearch

Abstracts

In this report, the global Pulmonary Arterial Hypertension (PAH) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pulmonary Arterial Hypertension (PAH) Drugs in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Pulmonary Arterial Hypertension (PAH) Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Actelion Pharmaceuticals
• DAIICHI SANKYO
• GlaxoSmithKline
• Novartis
• United Therapeutics
• AADi
• Actelion Pharmaceuticals
• Aires Pharmaceuticals
• Arena Pharmaceuticals
• Asklepion Pharmaceuticals
• AstraZeneca
• Bayer Healthcare
• Berlin Cures
• BIAL
• Eiger BioPharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Inhalation
• Injectables
• Oral administration

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Pulmonary Arterial Hypertension (PAH) Drugs for each application, including

• ERAs
• Prostacyclin analogs
• PDE inhibitors
• sGC stimulators

Contents

Global Pulmonary Arterial Hypertension (PAH) Drugs Market Research Report 2017

1 PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Pulmonary Arterial Hypertension (PAH) Drugs
1.2 Pulmonary Arterial Hypertension (PAH) Drugs Segment by Type (Product Category)
  1.2.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
  1.2.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share by Type (Product Category) in 2016
  1.2.3 Inhalation
  1.2.4 Injectables
  1.2.5 Oral administration
1.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Segment by Application
  1.3.1 Pulmonary Arterial Hypertension (PAH) Drugs Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 ERAs
  1.3.3 Prostacyclin analogs
  1.3.4 PDE inhibitors
  1.3.5 sGC stimulators
1.4 Global Pulmonary Arterial Hypertension (PAH) Drugs Market by Region (2012-2022)
  1.4.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Pulmonary Arterial Hypertension (PAH) Drugs (2012-2022)
  1.5.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Status and Outlook (2012-2022)
  1.5.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Pulmonary Arterial Hypertension (PAH) Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Pulmonary Arterial Hypertension (PAH) Drugs Market Competitive Situation and Trends
  2.5.1 Pulmonary Arterial Hypertension (PAH) Drugs Market Concentration Rate
  2.5.2 Pulmonary Arterial Hypertension (PAH) Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Production and Market Share by Region (2012-2017)
3.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption by Region (2012-2017)
4.2 North America Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Production and Market Share by Type (2012-2017)
5.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Price by Type (2012-2017)
5.4 Global Pulmonary Arterial Hypertension (PAH) Drugs Production Growth by Type (2012-2017)

6 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Actelion Pharmaceuticals
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 DAIICHI SANKYO
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Novartis Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 United Therapeutics
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 AADi
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 AADi Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Actelion Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Aires Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Arena Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Asklepion Pharmaceuticals
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Pulmonary Arterial Hypertension (PAH) Drugs Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 AstraZeneca
7.12 Bayer Healthcare
7.13 Berlin Cures
7.14 BIAL
7.15 Eiger BioPharmaceuticals

8 PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS MANUFACTURING COST ANALYSIS

8.1 Pulmonary Arterial Hypertension (PAH) Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Pulmonary Arterial Hypertension (PAH) Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) DRUGS MARKET FORECAST (2017-2022)

12.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Price and Trend Forecast (2017-2022)
12.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Pulmonary Arterial Hypertension (PAH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Pulmonary Arterial Hypertension (PAH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Pulmonary Arterial Hypertension (PAH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Pulmonary Arterial Hypertension (PAH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Pulmonary Arterial Hypertension (PAH) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Pulmonary Arterial Hypertension (PAH) Drugs
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Inhalation
Table Major Manufacturers of Inhalation
Figure Product Picture of Injectables
Table Major Manufacturers of Injectables
Figure Product Picture of Oral administration
Table Major Manufacturers of Oral administration
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption (K Units) by Applications (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Market Share by Applications in 2016
Figure ERAs Examples
Figure Prostacyclin analogs Examples
Figure PDE inhibitors Examples
Figure sGC stimulators Examples
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Major Players Product Capacity (K Units) (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity (K Units) of Key Manufacturers in 2016
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity (K Units) of Key Manufacturers in 2017
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Major Players Product Production (K Units) (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) of Key Manufacturers (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Pulmonary Arterial Hypertension (PAH) Drugs Production Share by Manufacturers
Figure 2017 Pulmonary Arterial Hypertension (PAH) Drugs Production Share by Manufacturers
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Manufacturers
Table 2017 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Manufacturers
Table Global Market Pulmonary Arterial Hypertension (PAH) Drugs Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Pulmonary Arterial Hypertension (PAH) Drugs Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Pulmonary Arterial Hypertension (PAH) Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Pulmonary Arterial Hypertension (PAH) Drugs Product Category
Figure Pulmonary Arterial Hypertension (PAH) Drugs Market Share of Top 3 Manufacturers
Figure Pulmonary Arterial Hypertension (PAH) Drugs Market Share of Top 5 Manufacturers
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity (K Units) by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity Market Share by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity Market Share by Region
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Production by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share by Region
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share by Region
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption (K Units) Market by Region (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Market Share by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption (K Units) Market Share by Region
Table North America Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Type
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Pulmonary Arterial Hypertension (PAH) Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Pulmonary Arterial Hypertension (PAH) Drugs by Type
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Price (USD/Unit) by Type (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Production Growth by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption (K Units) by Application (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Market Share by Application (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Market Share by Application in 2016
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Growth Rate by Application (2012-2017)
Table Actelion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table DAIICHI SANKYO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure DAIICHI SANKYO Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure Novartis Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure Novartis Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table United Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure United Therapeutics Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table AADi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AADi Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AADi Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure AADi Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure AADi Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table Actelion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table Aires Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure Aires Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table Asklepion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Growth Rate (2012-2017)
Figure Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share (2012-2017)
Figure Asklepion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pulmonary Arterial Hypertension (PAH) Drugs
Figure Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Drugs
Figure Pulmonary Arterial Hypertension (PAH) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Drugs Major Manufacturers in 2016
Table Major Buyers of Pulmonary Arterial Hypertension (PAH) Drugs
Table Distributors/Traders List
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) Forecast by Region (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Pulmonary Arterial Hypertension (PAH) Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) Forecast by Type (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Production (K Units) Forecast by Type (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Price Forecast by Type (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source